Cortiva Silhouette®
The thinnest cut for exceptional pliability
Cut exclusively from the middle dermis, and with the thinnest dimensions available, Cortiva Silhouette® allograft dermis is one of the most pliable acellular dermal matrices (ADM) on the market.1

Exceptional pliability

Dermis thickness is one of the characteristics that impacts the handling experience, such as pliability and conformability. A lower Drape Tissue Distance (DTD) score indicates a greater degree of pliability.1
Cortiva Silhouette® allograft dermis demonstrated a greater degree of pliability and conformability than other leading ADMs.1
« SCROLL »
Pliability score for Cortiva Silhouette® allograft dermis, FlexHD Pliable, Thin, and AlloDerm RTM, Medium, using the standardized pliability drape test at various DTD. Implants were prepared per labeling.
Standardized pliability drape test
Pliability is measured using a standardized drape test, with lower scores indicating a greater degree of pliability and conformity around the standardized block.

Uncompromised strength

Middle dermis
Cortiva Silhouette® allograft dermis grafts are cut from a deeper layer of the dermis, without the basement membrane, to remove orientation and to support greater pliability.1
Surgical strength
The mechanical strength of Cortiva Silhouette® allograft dermis is comparable to other biomaterials used in surgery where mechanical strength is important.1,2,‡
Cortiva Silhouette® allograft dermis results are relative to comparable biomaterials as reported in the literature and are not head-to-head.

Exceptional handling predictability

Excellent conformability
Superior thickness tolerances and pliability allow Cortiva Silhouette® allograft dermis to conform more closely to contoured and complex surfaces, as seen in this image with FlexHD Pliable, Thin.1

Surgical graft options

Cut exclusively from the middle of the dermis, and with the thinnest dimensions available, Cortiva Silhouette® allograft dermis is one of the most pliable ADMs on the market.1

Thickness

0.45-0.7mm

Rehydration time

At least 30 seconds

Tolerance

+/- 0.125mm

Size options

2 x 4cm to 16 x 20cm

Dermal cut

Dermis without basement membrane (no orientation)

Cortiva Silhouette® allograft dermis
UTD0204
2 x 4cm
UTD0407
4 x 7cm
UTD0412
4 x 12cm
UTD0416
4 x 16cm
UTD0508
5 x 8cm
UTD0612
6 x 12cm
UTD0616
6 x 16cm
UTD0710
7 x 10cm
UTD0812
8 x 12cm
UTD0816
8 x 16cm
UTD0820
8 x 20cm
UTD1015
10 x 15cm
UTD1620
16 x 20cm

Coordinate implant ordering with your local representative:

800-624-7238

customerservice@evergenbio.com
References
  1. Data on file at Evergen.
  2. Deeken CR, Lake SP. "Mechanical properties of the abdominal wall and biomaterials utilized for hernia repair." J Mech Behav Biomed Mater. 2017
    Oct;74:411-427.
‡ Lab data may not be representative of effects or performance in humans.
DESCRIPTION
Cortiva® 1mm, Cortiva® 1mm Tailored, Cortiva® 1mm Perforated, and Cortiva Silhouette® allograft dermis are dehydrated dermis from donated human tissue processed through the Tutoplast® tissue sterilization process. The implants are preserved by the Tutoplast® tissue sterilization process which retains the three-dimensional collagen structure responsible for the multidirectional, mechanical properties of the original dermal tissue. These implants are regulated as 361 human cell and tissue product (HCT/Ps) as defined in US FDA 21 CFR 1271 and are restricted to homologous use for the repair, replacement, reconstruction or augmentation of soft tissue by a qualified healthcare professional (e.g., physician). These implants are provided sterile and require rehydration prior to use.
WARNINGS
CORTIVA SILHOUETTE, CORTIVA 1MM PERFORATED, CORTIVA 1MM: The same potential medical/surgical conditions or complications that apply to any surgical procedure may occur during or following implantation. The surgeon is responsible for informing the patient of the risks associated with their treatment and the possibility of complications or adverse reactions. As with any human tissue implant, the potential for transmission of infectious agents may exist. A small number of patients may experience localized immunological reactions to the implant. Successful treatment is dependent upon the patient’s host tissue response. Resorption of the implant and commensurate substitution with functional host tissue is required to restore function. CORTIVA SILHOUETTE: Do not use the implant for abdominal wall repair, hernia repair or for other procedures that require substantial tensile strength. The implant should be used only where it is under minor to moderate tension. CORTIVA 1MM PERFORATED: Do not use the implant for abdominal wall repair, hernia repair or for other procedures that require substantial tensile strength. The implant should be used only where it is under minor to moderate tension. Do not further perforate the implant. Additional perforations may affect implant performance. CORTIVA 1MM TAILORED: The same medical/surgical conditions or complications that apply to any surgical procedure may occur during or following implantation. The surgeon is responsible for informing the patient of the risks associated with their treatment and the possibility of complications or adverse reactions. As with any human tissue implant, the potential for transmission of infectious agents may exist. A small number of patients may experience localized immunological reactions to the implant. Successful treatment is dependent upon the patient’s host tissue response. Resorption of the implant and commensurate substitution with functional host tissue is required to restore function.
PRECAUTIONS
Prior to use, the surgeon must become familiar with the implant and the surgical procedure. Poor general medical condition or any pathology that would limit the blood supply and compromise healing should be considered when selecting patients for procedures using this implant; as such conditions may compromise outcomes. The implant should be used with caution in surgical sites where an active infection is present or in sites with poor perfusion. If the surgeon determines that the clinical circumstances require implantation in a site that is contaminated or infected, appropriate local and/or systemic anti-infective measures should be taken. Appropriate placement and fixation of the implant are critical to the success of the surgical procedure.
All Cortiva® and Cortiva Silhouette® allograft dermis implants are processed by RTI Surgical, Inc. (Alachua, FL).

Please refer to the labeling for complete instructions for use.
Regulatory approvals vary by country. Therefore, we kindly ask you to contact the distributor in your region regarding availability of specific products in your region.

® indicates U.S. trademark registration. All trademarks and/or images are the property of their respective owners or holders.
© Evergen 2025 / RTI Surgical, Cook BioTech and Collagen Solutions are now Evergen. All rights reserved.
‍
Distributed by:
Evergen
11621 Research Circle
Alachua, FL 32615 USA
T 877.343.6832
evergenbio.com
DESCRIPTION
Cortiva® 1mm, Cortiva® 1mm Tailored, Cortiva® 1mm Perforated, and Cortiva Silhouette® allograft dermis are dehydrated dermis from donated human tissue processed through the Tutoplast® Tissue Sterilization process. The implants are preserved by the Tutoplast® tissue sterilization process which retains the three dimensional collagen structure responsible for the multidirectional, mechanical properties of the original dermal tissue. These implants are regulated as 361 human cell and tissue product (HCT/Ps) as defined in US FDA 21 CFR 1271 and are restricted to homologous use for the repair, replacement, reconstruction or augmentation of soft tissue by a qualified healthcare professional (e.g.,physician). These implants are provided sterile and require rehydration prior to use.
WARNINGS
CORTIVA SILHOUETTE, CORTIVA 1MM PERFORATED, CORTIVA 1MM: The same potential medical/surgical conditions or complications that apply to any surgical procedure may occur during or following implantation. Thesurgeon is responsible for informing the patient of the risks associated with their treatment and the possibility of complications or adverse reactions. As with any human tissue implant, the potential for transmission of infectious agents may exist. A small number of patients may experience localized immunological reactions to the implant. Successful treatment is dependent upon the patient’s host tissue response. Resorption of the implant and commensurate substitution with functional host tissue is required to restore function. CORTIVA SILHOUETTE: Do not use the implant for abdominal wall repair, hernia repair or for other procedures that require substantial tensile strength. The implant should be used only where it is under minor to moderate tension. CORTIVA PERFORATED: Do not use the implant for abdominal wall repair, hernia repair or for other procedures that require substantial tensile strength. The implant should be used only where it is under minor to moderate tension. Do not further perforate the implant. Additional perforations may affect implant performance CORTIVA 1MM TAILORED: The same medical/surgical conditions or complications that apply to any surgical procedure may occur during or following implantation. The surgeon is responsible for informing the patient of the risks associated with their treatment and the possibility of complications or adverse reactions. As with any human tissue implant, the potential for transmission of infectious agents may exist. A small number of patients may experience localized immunological reactions to the implant. Successful treatment is dependent upon the patient’s host tissue response. Resorption of the implant and commensurate substitution with functional host tissue is required to restore function.
PRECAUTIONS
Prior to use, the surgeon must become familiar with the implant and the surgical procedure. Poor general medical condition or any pathology that would limit the blood supply and compromise healing should be considered when selecting patients for procedures using this implant; as such conditions may compromise outcomes. The implant should be used with caution in surgical sites where an active infection is present or in sites with poor perfusion. If the surgeon determines that the clinical circumstances require implantation in a site that is contaminated or infected, appropriate local and/or systemic anti-infective measures should be taken. Appropriate placement and fixation of the implant are critical to the success of the surgical procedure.
Cortiva® allograft dermis and Cortiva Silhouette® are processed by RTI Surgical, Inc. (Alachua, FL).

Please refer to the labeling for complete instructions for use.
Regulatory approvals vary by country. Therefore, we kindly ask you to contact the distributor in your region regarding availability of specific products in your region.

® indicates U.S. trademark registration. All trademarks and/or images are the property of their respective owners or holders.
© Evergen 2025 / RTI Surgical, Cook BioTech and Collagen Solutions are now Evergen. All rights reserved.
‍
Distributed by
Evergen
11621 Research Circle
Alachua, FL 32615 USA
T 877.343.6832
evergenbio.com